作者: Mylene Dorvillius , Stephane Birkle , Denis Cochonneau , Mickael Terme , Doussal Jean-Marc Le
DOI:
关键词:
摘要: The present disclosure relates to an antibody recognizing the O-acetylated-GD2 ganglioside for treatment of Cancer Stem Cells (CSC) cancer. further concern a pharmaceutical composition comprising said treating CSC cancer and method in patient need thereof, administering patient. also diagnosing use 0-acetylated-GD2 as biomarker Finally, predicting response subject affected with or invention.